Vinpocetine for cognitive impairment and dementia

Blaha, 1989, Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome, Human Psychopharmacology, 4, 103, 10.1002/hup.470040205

Fenzl, 1986, Long-term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome, Senile dementias: early detection, 580

Hindmarch, 1991, Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes, International Clinical Psychopharmacology, 6, 31, 10.1097/00004850-199100610-00005

Balestreri, 1987, A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction, Journal of the American Geriatrics Society, 35, 425, 10.1111/j.1532-5415.1987.tb04664.x

Filimonov VA, 2007, Vinpotropile in the treatment of cerebral vascular diseases, Zh Nevrol Psikhiatr Im S S Korsakova, 2

Ivanova, 2008, The use of vinpotropile in chronic brain ishemia, Zh Nevrol Psikhiatr Im S S Korsakova, 1

Kishimoto, 1995, Auditory P300 event-related potentials and mini mental state examination performance in dementia; effects of Idebenone and Vinpocetine, Journal of Nara Medical Association, 46, 259

Kovacs L Comparative studies of cavinton no source

Kuznetsov, 2007, Implication of vinpotropile in the treatment of patients with cerebral stroke, Zh Nevrol Psikhiatr Im S S Korsakova, 52

Manconi, 1986, A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin, Current Therapeutic Research, 40, 702

Nesterova, 2008, Effect of vinpocetin on cerebral hemodynamics, autoregulation and cognitive frustration in senile patients with a chronic brain ischemia, Eur J Neurology, Supplement 1, 261

Peruzza, 1986, A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction, Advances in Therapeutics, 3, 201

Pitzus F A double-blind parallel group placebo controlled evaluation of the safety and efficacy of Vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction Unknown

Tanashyan, 2007, The use of vinpocetine in the treatment of cognitive impairment in patients with cerebrovascular diseases, Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 107, 41

Thal, 1989, The safety and lack of efficacy of vinpocetine in Alzheimer's disease, Journal of the American Geriatrics Society, 37, 515, 10.1111/j.1532-5415.1989.tb05682.x

Valikovics, 2007, Investigation of the effect of vinpocetine on cerebral blood flow and cognitive  functions, Ideggyogy Sz., 60, 301

Vamosi, 1976, Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF, Arzneimittelforschung, 26, 1980

Wolters, 1992, A double blind placebo and piracetam controlled multicenter trial of vinpocetine in dementia of Alzheimer's type and vascular dementia, Neurobiology of Aging, 13, S127, 10.1016/0197-4580(92)90629-C

Zakharov VV. Lokshina AB. Stakhovskaia LV. Timerbaeva, 2007, The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency, Zh Nevrol Psikhiatr Im S S Korsakova, 107, 76

American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders

Bereczki, 1997, Vinpocetine for acute ischaemic stroke, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000480

Bönöczk, 2000, Role of sodium channel inhibiton in neuroprotection: effect of vinpocetine, Brain Research Bulletin, 53, 245, 10.1016/S0361-9230(00)00354-3

Coleston, 1988, Possible emeory-enhancing properties of vinpocetine, Drug Development and Research, 14, 191, 10.1002/ddr.430140306

DeNoble, 1986, Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats, Pharmacology and Biochemistry of Behaviour, 24, 1123, 10.1016/0091-3057(86)90465-X

DeNoble, 1987, Vinpocetine enhances retrieval of a step-through passive avoidance response in rats, Pharmacology and Biochemistry of Behaviour, 26, 183, 10.1016/0091-3057(87)90552-1

Erdo, 1990, Vinpocetine protects against excitotoxic cell death in primary cultures of rat cerebral cortex, European Journal of Pharmacology, 187, 551, 10.1016/0014-2999(90)90386-K

Erzigkeit, 1986, Manual zum SKT. Formen A-E

Folstein, 1975, Mini-mental state: A practical method for grading cognitive state of patients for the clinician, Journal of Psychiatric Research, 12, 189, 10.1016/0022-3956(75)90026-6

Guy, 1976, Clinical Global assessment Scale (CGI), ECDEU Assessment Manual for Psychopharmacology, 218

Hayakawa, 1992, Effect of vinpocetine on red blood cell deformability in stroke patients, Arzneim-Forsch/Drug Research, 42, 425

Krieglstein, 1991, Vinpocetine increases the neuroprotective effect of adenosine in vitro, European Journal of Pharmacology, 205, 7, 10.1016/0014-2999(91)90762-F

Kuzuya, 1982, Effects of vinpocetine on platelet aggregability and erythrocyte deformability, Geriatric Medicine, 20, 151

Lauter, 1980, Psychologie des 20 Jahrhunderts, Demenzen, X, Psychiatrie, 637

McKhann, 1984, Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 4, 939, 10.1212/WNL.34.7.939

Molnár, 1995, Vinpocetine is as potent as phenytoin to block voltage-gated Na channels in rat cortical neurons, European Journal of Pharmacology, 27, 303, 10.1016/0014-2999(94)00755-V

Mulrow CD Oxman AD Cochrane Collaboration Handbook 1997

Nagy, 1998, Meta-analysis of cavinton, Praxis, 7, 1

Rataud, 1994, Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodens, Neuroscience Letters, 172, 19, 10.1016/0304-3940(94)90652-1

Román, 1993, Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS -AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250

Szakall, 1998, Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study, Journal of Neuroimaging, 8, 197, 10.1111/jon199884197

World Health Organisation, 1992, International Classification of Disease (ICD-10)

Szatmari, 2003, Vinpocetine for cognitive impairment and dementia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003119